Company intelligence / Profile preview

Ranbaxy Laboratories

Gurgaon, Haryana, India

Ownership: Private
Employees: ~14000
Development stage: Other

Overview

Ranbaxy Laboratories was a major Indian generic pharmaceutical company with a significant global footprint, manufacturing and marketing small-molecule drugs across therapeutic categories. The company ran into compliance and drug safety issues and was acquired by Sun Pharma in 2014, after which Ranbaxy ceased to operate as an independent entity.

Modalities: Small molecule
Industry: Biotech

Partnerships

Eli Lilly (joint marketing agreement, 1992)Bayer (development/marketing deal, 1999)

Beyond the preview

Go deeper on Ranbaxy Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ranbaxy Laboratories.

Explore the full profile